Xianya Qin

1.1k total citations
23 papers, 878 citations indexed

About

Xianya Qin is a scholar working on Biomedical Engineering, Immunology and Molecular Biology. According to data from OpenAlex, Xianya Qin has authored 23 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Biomedical Engineering, 13 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Xianya Qin's work include Nanoplatforms for cancer theranostics (16 papers), Immunotherapy and Immune Responses (11 papers) and Extracellular vesicles in disease (5 papers). Xianya Qin is often cited by papers focused on Nanoplatforms for cancer theranostics (16 papers), Immunotherapy and Immune Responses (11 papers) and Extracellular vesicles in disease (5 papers). Xianya Qin collaborates with scholars based in China, United States and Sweden. Xianya Qin's co-authors include Qi Qiao, Zhiping Zhang, Conglian Yang, Tingting Wu, Qingle Song, Zhiping Zhang, Dan Zhang, Li Kong, Lihuan Shang and Qian Hu and has published in prestigious journals such as Nano Letters, ACS Nano and Biomaterials.

In The Last Decade

Xianya Qin

23 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianya Qin China 17 524 347 291 211 139 23 878
Yunai Du China 9 549 1.0× 232 0.7× 217 0.7× 203 1.0× 120 0.9× 11 778
Huihai Zhong China 16 536 1.0× 320 0.9× 245 0.8× 217 1.0× 134 1.0× 21 887
Alba Nicolás‐Boluda France 16 362 0.7× 326 0.9× 168 0.6× 182 0.9× 220 1.6× 27 935
Elizabeth E. Sweeney United States 15 470 0.9× 235 0.7× 243 0.8× 109 0.5× 202 1.5× 21 786
Luan N. Nguyen Canada 15 351 0.7× 445 1.3× 165 0.6× 213 1.0× 233 1.7× 26 996
Jiwoong Choi South Korea 14 497 0.9× 281 0.8× 215 0.7× 259 1.2× 226 1.6× 24 844
Jie Zang China 17 481 0.9× 341 1.0× 234 0.8× 239 1.1× 79 0.6× 28 838
Brandon Piel United States 8 415 0.8× 472 1.4× 336 1.2× 409 1.9× 287 2.1× 10 1.2k
Lisa E. Cole United States 16 459 0.9× 323 0.9× 203 0.7× 213 1.0× 190 1.4× 20 1.0k
Nobutaka Iwakuma Japan 16 382 0.7× 171 0.5× 164 0.6× 178 0.8× 217 1.6× 42 872

Countries citing papers authored by Xianya Qin

Since Specialization
Citations

This map shows the geographic impact of Xianya Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianya Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianya Qin more than expected).

Fields of papers citing papers by Xianya Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianya Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianya Qin. The network helps show where Xianya Qin may publish in the future.

Co-authorship network of co-authors of Xianya Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Xianya Qin. A scholar is included among the top collaborators of Xianya Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianya Qin. Xianya Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Huiqi, et al.. (2025). Global landscape of clinical trials for endometriosis: dynamic trends and future directions. International Journal of Surgery. 111(10). 7355–7358. 1 indexed citations
2.
Zhang, Jiao, et al.. (2024). A laponite-based immunologically active gel delivery system for long-acting tumor vaccine. Journal of Controlled Release. 373. 201–215. 2 indexed citations
3.
Qin, Xianya, Hongbo Xu, Siyu Zhao, et al.. (2024). A novel biosynthesized vaccine based on tumor cells for peritoneal metastasis treatment in colon cancer. Chemical Engineering Journal. 484. 149224–149224. 5 indexed citations
4.
Xu, Hongbo, Xianya Qin, Yuanyuan Guo, et al.. (2024). Radiation-based immunogenic vaccine combined with a macrophage “checkpoint inhibitor” for boosting innate and adaptive immunity against metastatic colon cancers. Acta Pharmaceutica Sinica B. 14(5). 2247–2262. 4 indexed citations
5.
Li, Xiaonan, Qi Qiao, Qian Hu, et al.. (2024). Engineered Biomimetic Nanovesicles Based on Neutrophils for Hierarchical Targeting Therapy of Acute Respiratory Distress Syndrome. ACS Nano. 18(2). 1658–1677. 23 indexed citations
6.
Yu, Yulin, Yang Li, Xianya Qin, et al.. (2024). Self-generated double-stranded RNA for enhancing tumor immunotherapy and metastasis inhibition. Nano Today. 55. 102173–102173. 5 indexed citations
7.
Qin, Xianya, Ting Yang, Hongbo Xu, et al.. (2023). Dying tumor cells-inspired vaccine for boosting humoral and cellular immunity against cancer. Journal of Controlled Release. 359. 359–372. 18 indexed citations
8.
Han, Henry, Wentian Li, Jiacun Wang, Guimin Qin, & Xianya Qin. (2022). Enhance Explainability of Manifold Learning. SSRN Electronic Journal. 1 indexed citations
9.
Zhang, Dan, Pengran Liu, Xianya Qin, et al.. (2022). HSA-templated self-generation of gold nanoparticles for tumor vaccine delivery and combinational therapy. Journal of Materials Chemistry B. 10(42). 8750–8759. 16 indexed citations
10.
Han, Henry, Wentian Li, Jiacun Wang, Guimin Qin, & Xianya Qin. (2022). Enhance explainability of manifold learning. Neurocomputing. 500. 877–895. 49 indexed citations
11.
Tu, Kun, Yulin Yu, Yi Wang, et al.. (2021). Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade. ACS Applied Materials & Interfaces. 13(33). 39003–39017. 51 indexed citations
12.
Qin, Xianya, Conglian Yang, Dan Zhang, et al.. (2021). Cell‐Derived Biogenetic Gold Nanoparticles for Sensitizing Radiotherapy and Boosting Immune Response against Cancer. Small. 17(50). e2103984–e2103984. 61 indexed citations
13.
Tu, Jingyao, Kun Tu, Haoran Xu, et al.. (2020). Improving tumor hypoxia and radiotherapy resistance via in situ nitric oxide release strategy. European Journal of Pharmaceutics and Biopharmaceutics. 150. 96–107. 20 indexed citations
14.
Wu, Tingting, Qi Qiao, Xianya Qin, Dan Zhang, & Zhiping Zhang. (2019). Immunostimulatory cytokine and doxorubicin co-loaded nanovesicles for cancer immunochemotherapy. Nanomedicine Nanotechnology Biology and Medicine. 18. 66–77. 21 indexed citations
15.
Zhang, Dan, Xianya Qin, Tingting Wu, et al.. (2019). Extracellular vesicles based self-grown gold nanopopcorn for combinatorial chemo-photothermal therapy. Biomaterials. 197. 220–228. 83 indexed citations
16.
Zhang, Dan, Tingting Wu, Xianya Qin, et al.. (2019). Intracellularly Generated Immunological Gold Nanoparticles for Combinatorial Photothermal Therapy and Immunotherapy against Tumor. Nano Letters. 19(9). 6635–6646. 196 indexed citations
17.
Hu, Xiaomeng, Tingting Wu, Xianya Qin, et al.. (2018). Tumor Lysate‐Loaded Lipid Hybrid Nanovaccine Collaborated with an Immune Checkpoint Antagonist for Combination Immunotherapy. Advanced Healthcare Materials. 8(1). e1800837–e1800837. 28 indexed citations
18.
Yang, Conglian, Tingting Wu, Yan Qi, et al.. (2018). A facile doxorubicin-dichloroacetate conjugate nanomedicine with high drug loading for safe drug delivery. International Journal of Nanomedicine. Volume 13. 1281–1293. 26 indexed citations
19.
Qi, Yan, Xianya Qin, Conglian Yang, et al.. (2018). Micelle System Based on Molecular Economy Principle for Overcoming Multidrug Resistance and Inhibiting Metastasis. Molecular Pharmaceutics. 15(3). 1005–1016. 18 indexed citations
20.
Wu, Tingting, Dan Zhang, Qi Qiao, et al.. (2018). Biomimetic Nanovesicles for Enhanced Antitumor Activity of Combinational Photothermal and Chemotherapy. Molecular Pharmaceutics. 15(3). 1341–1352. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunai Du Breakdown of academic impact, for papers by Huihai Zhong Breakdown of academic impact, for papers by Alba Nicolás‐Boluda Breakdown of academic impact, for papers by Elizabeth E. Sweeney Breakdown of academic impact, for papers by Luan N. Nguyen Breakdown of academic impact, for papers by Jiwoong Choi Breakdown of academic impact, for papers by Jie Zang Breakdown of academic impact, for papers by Brandon Piel Breakdown of academic impact, for papers by Lisa E. Cole Breakdown of academic impact, for papers by Nobutaka Iwakuma
Rankless by CCL
2026